WeVote
Log In

Bill

Bill

HB 1670

Health insurance; cost-sharing for epinephrine injectors.

2025 Regular Session Introduced by Mike Jones

Virginia bill eliminating health insurance cost-sharing for epinephrine auto-injectors to improve access to emergency allergy medications.

Left in Labor and Commerce
0
WeVote Research Nonpartisan
Bill Summary · HB 1670

Legislative bill overview

HB 1670 would modify Virginia's health insurance regulations to limit or eliminate cost-sharing (copayments, coinsurance, deductibles) for epinephrine auto-injectors (EpiPens). The bill aims to ensure that individuals with severe allergies can access these life-saving devices without financial barriers at the point of care.

Why is this important

Epinephrine auto-injectors are emergency medications for anaphylaxis, a potentially fatal allergic reaction. High out-of-pocket costs can discourage people from carrying or using these devices, creating public health risks. Additionally, epinephrine prices have risen significantly in recent years, making cost-sharing removal a practical policy consideration for allergy sufferers.

Potential points of contention

  • Insurance cost impact: Eliminating cost-sharing increases insurer expenses, which may be passed to consumers through higher premiums
  • Scope concerns: Whether the mandate should apply to all health plans (including self-insured employers) or just state-regulated insurers
  • Alternative solutions: Debate over whether drug price negotiation or manufacturer assistance programs are more efficient than insurance mandates

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.